Semiautomatic analysis of tumor proportion in colon cancer: Lessons from a validation study.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 09 07 2021
revised: 23 09 2021
accepted: 24 09 2021
pubmed: 11 10 2021
medline: 3 3 2022
entrez: 10 10 2021
Statut: ppublish

Résumé

The tumor stroma ratio (TSR) is a promising histopathologic prognostic biomarker, which could allow for more accurate risk stratification and improved patient management in colorectal cancer. The purpose of our research was to validate the results of a previous study, which had suggested that not only a low but also a high tumor proportion (TP) might be an independent risk factor for occurrence of distant metastasis and worse overall survival using a semiautomatic image analysis approach with the open-source software ImageJ. We investigated 253 pT3 and pT4 adenocarcinomas of no special type. The previously established thresholds (PES-cut-offs) used to classify the patients (previous 3-tiered-classification) according to the tumor proportion (TP) in a highTP (TP ≥ 54%), a mediumTP (TP < 54% ∩ TP >15%) and a lowTP (TP ≤ 15%) group did not show a significant risk stratification. Even the adjustment of these threshold revealed no significant results. Therefore, a receiver-operating characteristic (ROC) analysis was performed to establish the cut-off with the most significant predictive power and a "new 2-tiered-classification" using this cut-off (40% at MinTP) showed a significantly shorter absence of metastasis for patients with a low TP (p = 0.007). These results confirm that a low TP is associated with an adverse prognosis. This study did not confirm the previous assumption that a high TP might also be a risk factor for occurrence of metastasis. Furthermore, it demonstrates that this semiautomatic technique is not superior to the established method, so that approaches to enhance prognostic techniques should continue.

Identifiants

pubmed: 34628263
pii: S0344-0338(21)00295-8
doi: 10.1016/j.prp.2021.153634
pii:
doi:

Types de publication

Comparative Study Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

153634

Informations de copyright

Copyright © 2021 Elsevier GmbH. All rights reserved.

Auteurs

Silvia Miller (S)

General Pathology and Molecular Diagnostics, Medical Faculty Augsburg, University Augsburg, Germany.

Svenja Bauer (S)

General Pathology and Molecular Diagnostics, Medical Faculty Augsburg, University Augsburg, Germany.

Matthias Schrempf (M)

Department of Visceral Surgery, University Hospital Augsburg, Augsburg, Germany.

Gerhard Schenkirsch (G)

Tumor Data Management, University Hospital Augsburg, Augsburg, Germany.

Andreas Probst (A)

Medicine III - Gastroenterology, Medical Faculty Augsburg, University Augsburg, Germany.

Bruno Märkl (B)

General Pathology and Molecular Diagnostics, Medical Faculty Augsburg, University Augsburg, Germany. Electronic address: bruno.maerkl@uka-science.de.

Benedikt Martin (B)

General Pathology and Molecular Diagnostics, Medical Faculty Augsburg, University Augsburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH